Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Nørreris Bioenergi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   2.4% 2.7% 1.5% 1.1% 5.3% 1.2% 8.5% 8.5%   Credit score (0-100)   65 62 77 84 42 80 29 29   Credit rating   BBB BBB A A BBB A BB BB   Credit limit (kDKK)   -0.0 0.0 16.0 361.3 0.0 134.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,150 4,448 7,069 8,461 2,441 6,453 0.0 0.0   EBITDA   982 3,939 6,478 8,056 1,983 6,376 0.0 0.0   EBIT   -120 974 3,573 5,197 -905 3,455 0.0 0.0   Pre-tax profit (PTP)   -1,158.5 -304.3 2,213.6 4,108.1 -1,731.4 2,511.8 0.0 0.0   Net earnings   -904.1 -237.4 1,726.6 3,204.4 -1,350.5 1,959.2 0.0 0.0   Pre-tax profit without non-rec. items   -1,158 -304 2,214 4,108 -1,731 2,512 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   29,474 31,832 28,659 25,799 23,347 21,326 0.0 0.0   Shareholders equity total   -853 -1,091 636 3,841 2,490 4,449 4,398 4,398   Interest-bearing liabilities   32,409 23,960 20,569 15,614 14,090 12,372 0.0 0.0   Balance sheet total (assets)   42,746 33,983 31,917 29,841 26,654 25,791 4,398 4,398   Net Debt   32,067 23,960 20,446 15,139 14,090 12,372 -4,398 -4,398     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,150 4,448 7,069 8,461 2,441 6,453 0.0 0.0   Gross profit growth   0.0% 286.8% 58.9% 19.7% -71.2% 164.4% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   42,746 33,983 31,917 29,841 26,654 25,791 4,398 4,398   Balance sheet change%   0.0% -20.5% -6.1% -6.5% -10.7% -3.2% -82.9% 0.0%   Added value   982.5 3,939.4 6,477.6 8,056.4 1,955.3 6,376.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   28,371 -607 -6,078 -5,720 -5,340 -4,942 -21,326 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -10.5% 21.9% 50.5% 61.4% -37.1% 53.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -0.3% 2.5% 10.7% 16.8% -3.2% 13.2% 0.0% 0.0%   ROI %   -0.4% 3.3% 14.0% 22.2% -4.5% 19.7% 0.0% 0.0%   ROE %   -2.1% -0.6% 10.0% 143.2% -42.7% 56.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -2.0% -3.1% 2.0% 12.9% 9.3% 17.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   3,264.0% 608.2% 315.6% 187.9% 710.4% 194.0% 0.0% 0.0%   Gearing %   -3,798.9% -2,197.1% 3,233.4% 406.5% 565.9% 278.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.4% 4.5% 6.1% 6.0% 5.6% 7.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.3 0.6 0.5 0.3 0.4 0.0 0.0   Current Ratio   0.9 0.3 0.6 0.7 0.4 0.6 0.0 0.0   Cash and cash equivalent   341.4 0.0 123.0 474.5 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,820.5 -4,065.5 -2,064.1 -1,527.8 -4,226.8 -3,073.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   982 3,939 6,478 8,056 1,955 6,376 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   982 3,939 6,478 8,056 1,983 6,376 0 0   EBIT / employee   -120 974 3,573 5,197 -905 3,455 0 0   Net earnings / employee   -904 -237 1,727 3,204 -1,351 1,959 0 0